L-NAPNA is a nitric oxide synthase (NOS) inhibitor with an IC50 of 1.4 µM. L-NAPNA exhibits analgesic effects by inhibiting formalin-induced paw licking behavior in mice (ED50 of 57.2 mg/kg) and suppressing acetic acid-induced abdominal writhing in mice (ED50 of 25 mg/kg). L-NAPNA can be used in research related to central nervous system diseases[1].
Molekulargewicht:
339.31
CAS Nummer:
[85697-89-8]
Formel:
C12H17N7O5
Target-Kategorie:
NO Synthase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
